BackgroundGroup B streptococcus (GBS) has been implicated in adverse pregnancy outcomes. GBS recto-vaginal colonization rates significantly vary among different communities and geographic locations. Limited data is available on the prevalence and effects of GBS recto-vaginal colonization among pregnant mothers in developing countries like Ethiopia.ObjectiveTo assess the prevalence of GBS recto-vaginal colonization among near term pregnant mothers and the antimicrobial susceptibility pattern of the isolates.MethodsA cross sectional descriptive study was conducted on pregnant mothers at gestational age of 35–37 weeks attending Ante Natal Clinics at Ghandi Memorial (GMH) and Tikur Anbessa Specialized Hospital (TASH) in Addis Ababa. Samples from lower genital tract and rectum were collected and cultured for GBS on CHROM agar Strep B.ResultsTwenty two of the 300 pregnant mothers (7.2%) studied were found to have positive GBS recto-vaginal culture. Twelve isolates (55%) were sensitive to penicillin while 20 (91%) were sensitive to ampicilline. All isolates except one were sensitive to Erythromycin.ConclusionThe study showed recto-vaginal GBS colonization among near term pregnant mothers is reasonably high in our community calling for the need to screen mothers near term and provide appropriate antimicrobial prophylaxis to prevent potential adverse maternal and neonatal outcome.

Back ground: Severe respiratory tract infection caused by family of Corona viruses has become world pandemic and is claiming many lives. In this study we have described the first 33 cases diagnosed, admitted and treated in Ethiopia COVID treatment center with the aim of contributing some information to the local and global effort of controlling the pandemic.Method: Descriptive study was conducted on the first 33 consecutive RT-PCR confirmed COVID 19 cases diagnosed and managed at Ekka-Kotebe COVID treatment center in Addis Ababa, Ethiopia.Result: Data of the first 33 COVID 19 confirmed patients treated at Ekka-kotebe COVID treatment center was analyzed. The median age of the cases was 36 years. Cough, headache and fever were the most frequent symptoms in the firs 33 COVID 19 cases reported in this study. Diarrhea, sore throats, loss of taste and/or smell sensation were among the rare symptoms. Most (84.8%) had mild to moderate disease and 15.2%(n = 5) were critical at the time of admission. Among the five ICU admissions, four patients required invasive mechanical ventilation. Both mild and moderate cases were managed in the general ward with or without low flow oxygen treatment. Thirty cases were discharged after two pairs of nasopharyngeal and oropharyngeal samples turned negative for SARS CoV2. Three cases from the ICU died while on mechanical ventilator. Age of the two deaths was 65 years and one was 60 years. With the exception of three, all cases were either imported from abroad or had contact with confirmed case.

and extended hospital stays. Non-serious complications included formation of a hematoma, discoloration, oozing, swelling, or bleeding at the entry site. P values < 0.05 were considered significant. Results: An independent T-test indicated a significant (p < .001) increase in the mean percentage in the number of reused SUDs at BBH. There was no difference in the number of complications that developed after surgery between the hospitals, despite the significant difference in the number of SUDs per procedure. When analyzing length of stay, the results showed significant (p < .001) increase in the average mean stay for patients in BBH which may be attributed to the initial health status of patients. No significant differences were found between hospitals in the severity of complications was analyzed (serious vs. non-serious). Conclusion: There was no significant correlation between the reuse of single use medical devices and adverse outcomes for PTCA at either of the two hospitals in which the study took place.

No abstract